FDA Draft Infusion Pump Guidance

The Food and Drug Administration (FDA) has posted a draft revised guidance for infusion pumps. This guidance is part of a major FDA initiative to enhance infusion pump safety. It has many references to software and software hazards. It also indicates an assurance/safety case should be provided rather than just a risk analysis. Although this guidance is for infusion pumps it may be indicative of the FDA’s future expectations for other devices and their software as well.

Schedule Discussion with John F. Murray, Jr.

John is currently providing telephone and face-to-face meetings to discuss:  Cybersecurity, Part 11, 483 Response, design controls expectations for software documentation, and other topics.

Leave a message and we will contact you to schedule:

Corporate Office

+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TN) and Italy.